Stock ALPAT PLANT ADVANCED TECHNOLOGIES
Add to a list
To use this feature you must be a member
Log inSign up

Financials Plant Advanced Technologies

Equities

ALPAT

FR0010785790

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 11:18:11 2024-04-26 am EDT 		5-day change 1st Jan Change
10.5 EUR 0.00% Intraday chart for Plant Advanced Technologies +2.94% +24.26%
Jan. 09 Plant Advanced Technologies Announces the Official Launch of Its Latest Active Ingredient, Hydraqueen Exudactive®?1,3, and the Upcoming Cosmetic Range as Part of Its New Business Strategy CI
2023 Plant Advanced Technologies SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 14.75 21.45 22.49 20.23 14.43 11.41 11.41 -
Enterprise Value (EV) 1 17.33 22.86 26.49 23.88 14.43 17.01 14.71 14.01
P/E ratio 18.3 x -39.6 x -34.1 x -17.7 x -17.1 x -15.7 x -525 x 18.8 x
Yield - - - - - - - -
Capitalization / Revenue 12.9 x 18.3 x 17.9 x 10.5 x 6.17 x 4.96 x 4.39 x 2.85 x
EV / Revenue 15.2 x 19.5 x 21.1 x 12.4 x 6.17 x 7.4 x 5.66 x 3.5 x
EV / EBITDA - - - - -37.1 x -21.3 x - 20 x
EV / FCF - - -53 x -47.4 x - -85.1 x 73.6 x 20 x
FCF Yield - - -1.89% -2.11% - -1.18% 1.36% 5%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 916 1,083 1,081 1,087 1,085 1,087 1,087 -
Reference price 2 16.10 19.80 20.80 18.60 13.30 10.50 10.50 10.50
Announcement Date 4/29/19 4/30/20 4/30/21 4/30/22 4/30/23 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1.141 1.173 1.256 1.927 2.339 2.3 2.6 4
EBITDA 1 - - - - -0.389 -0.8 - 0.7
EBIT 1 -2.115 -1.548 -1.596 -1.946 -1.454 -1.7 -1 -0.3
Operating Margin -185.36% -131.99% -127.07% -101.01% -62.16% -73.91% -38.46% -7.5%
Earnings before Tax (EBT) - - - - - - - -
Net income 1 0.865 -0.5412 -0.664 -1.134 -0.849 -0.8 - 0.7
Net margin 75.81% -46.15% -52.87% -58.86% -36.3% -34.78% - 17.5%
EPS 2 0.8800 -0.5000 -0.6100 -1.050 -0.7800 -0.6700 -0.0200 0.5600
Free Cash Flow 1 - - -0.5 -0.504 - -0.2 0.2 0.7
FCF margin - - -39.81% -26.16% - -8.7% 7.69% 17.5%
FCF Conversion (EBITDA) - - - - - - - 100%
FCF Conversion (Net income) - - - - - - - 100%
Dividend per Share - - - - - - - -
Announcement Date 4/29/19 4/30/20 4/30/21 4/30/22 4/30/23 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 2.59 1.41 4 3.65 - 5.6 3.3 2.6
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) - - - - - -7 x - 3.714 x
Free Cash Flow 1 - - -0.5 -0.5 - -0.2 0.2 0.7
ROE (net income / shareholders' equity) - - - - - - - 8%
ROA (Net income/ Total Assets) - - - - - - - 5.5%
Assets 1 - - - - - - - 12.73
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - - - 0.8 0.7 0.6
Capex / Sales - - - - - 34.78% 26.92% 15%
Announcement Date 4/29/19 4/30/20 4/30/21 4/30/22 4/30/23 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Plant Advanced Technologies

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.5 EUR
Average target price
11.5 EUR
Spread / Average Target
+9.52%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PLANT ADVANCED TECHNOLOGIES Stock Plant Advanced Technologies
+24.26% 12.18M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALPAT Stock
  4. Financials Plant Advanced Technologies